Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal membrane lipids and associated proteins represent the collective structural and functional assembly of the neuronal plasma membrane, comprising a diverse array of phospholipids, sphingolipids, cholesterol, and integral proteins [Sonnino & Prinetti, 2013, PubMed]. This complex environment is not merely a passive barrier but a dynamic platform where lipid microdomains, such as lipid rafts, organize signaling molecules like G protein-coupled receptors and ion channels to facilitate rapid neurotransmission [Simons & Sampaio, 2011, Nature Reviews Molecular Cell Biology]. In neurodegenerative diseases, the disruption of this lipid-protein architecture—such as the accumulation of amyloid-beta on ganglioside-rich membranes—is a primary driver of pathology [Schengrund, 2015, Journal of Lipid Research]. Therapeutic approaches, termed membrane lipid therapy, utilize lipid analogs or metabolic modulators to alter membrane fluidity and composition, thereby restoring normal protein function [Escribá et al., 2008, Journal of Cellular and Molecular Medicine]. While targeting the membrane as a whole offers a broad therapeutic window for complex diseases, it presents significant challenges in achieving cellular specificity and avoiding systemic toxicity [Maxfield & Tabas, 2005, Nature]. Drugs like propofol and certain polyunsaturated fatty acids exert their effects by partitioning into these membranes and altering the biophysical environment of key neuronal receptors [PubMed]. Consequently, this target is central to understanding the interplay between membrane physics and neurobiology.
Modulation of the biophysical properties of the lipid bilayer to indirectly regulate the function of embedded signaling proteins and ion channels.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal membrane lipids and associated proteins.